CDT
Price
$0.99
Change
-$0.26 (-20.80%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.46M
Intraday BUY SELL Signals
SLXN
Price
$0.26
Change
-$0.02 (-7.14%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.38M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDT vs SLXN

CDT vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CDT vs. SLXN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDT is a Hold and SLXN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
CDTSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
56%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
28%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CDT: $1.25 vs. SLXN: $0.28)
Brand notoriety: CDT and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDT: 226% vs. SLXN: 38%
Market capitalization -- CDT: $1.46M vs. SLXN: $1.38M
CDT [@Biotechnology] is valued at $1.46M. SLXN’s [@Biotechnology] market capitalization is $1.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDT’s FA Score shows that 1 FA rating(s) are green while SLXN’s FA Score has 0 green FA rating(s).

  • CDT’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, CDT is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDT’s TA Score shows that 2 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • CDT’s TA Score: 2 bullish, 2 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than CDT.

Price Growth

CDT (@Biotechnology) experienced а -58.68% price change this week, while SLXN (@Biotechnology) price change was +8.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

SLXN is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CDT
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHTR111.370.47
+0.42%
Charter Communications
CRAN10.10N/A
N/A
Crane Harbor Acquisition Corp II
DRCT1.51-0.01
-0.66%
Direct Digital Holdings Inc.
VERA30.99-1.30
-4.03%
Vera Therapeutics
CLST16.53-1.09
-6.19%
Catalyst Bancorp

CDT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDT has been loosely correlated with SLXN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CDT jumps, then SLXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDT
1D Price
Change %
CDT100%
-8.09%
SLXN - CDT
44%
Loosely correlated
+0.61%
CMND - CDT
32%
Poorly correlated
-11.09%
NRXP - CDT
27%
Poorly correlated
-2.40%
PEPG - CDT
26%
Poorly correlated
-8.68%
LTRN - CDT
25%
Poorly correlated
-0.99%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.61%
IMA - SLXN
62%
Loosely correlated
+0.22%
CELC - SLXN
50%
Loosely correlated
-5.52%
CDT - SLXN
44%
Loosely correlated
-8.09%
INKT - SLXN
36%
Loosely correlated
+1.43%
HYFT - SLXN
34%
Loosely correlated
+0.38%
More